Fondren Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,000	Closed	-$1.12M	–	75
2018 Q2	$1.12M	Buy	+35,000	New	+$1.12M	0.86%	33